Cord Serum Bilirubin Level in Predicting the Development of Significant Hyperbilirubinemia in Newborns with ABO Incompatibility

Authors

  • Sunita Arora Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar, Amritsar
  • - Shifali Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar, Amritsar

DOI:

https://doi.org/10.3126/jnps.v35i3.13797

Keywords:

Hyperbilirubinemia, Cord blood, Immune haemolytic disease, Bilirubin encephalopathy

Abstract

Introduction: Neonatal hyperbilirubinaemia is common problem which is benign in majority of neonates. Rh iso immune hemolytic disease as a cause of hyperbilirubinemia is becoming nearly nonexistent due to the use of prophylactic anti D. Hence Isoimmune hemolytic disease due to ABO incompatibility assumes significance as a cause of significant hyperbilirubinaemia. This study was conducted to determine the incidence of ABO incompatibility, ABO iso immune disease in new born, to determine critical cord serum bilirubin level to predict subsequent significant hyperbilirubinemia.

Material and Methods: The study was done in neonatal ICU of a tertiary care hospital where 100 full term healthy newborns with B.W≥2500gm and gestational age ≥37 wk with blood group A, B, AB, born to mothers with O blood group without simultaneous Rh incompatibility at SGRDIMSR were included. Serum bilirubin was measured approximately at 12-24hrs, 36-48hrs, 60-72hrs.

Results: Out 100 ABO incompatible newborns 33(33%) developed ABO isoimmune disease manifesting as significant hyperbilirubinaemia with any of the four total serum bilirubin levels exceeding threshold levels defined for phototherapy. TSB of ≥ 2.16mg/d1 from cord blood has a sensitivity of 100% specificity of 89.55%, NPV 100% and PPV of 82.50% to predict significant hyperbilirubinaemia.

Conclusion: A critical cord S.bilirubin between 2.16 mg/d1 and 4.09mg/d1 will predict all newborns who will have significant hyperbilirubinaemia and can be used as a safe demarcator to decide time of discharge. Any therapeutic intervention if necessary can be started as early as possible.

J Nepal Paediatr Soc 2015; 35(3): 231-236 

Downloads

Download data is not yet available.
Abstract
1143
PDF
1393

Author Biographies

Sunita Arora, Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar, Amritsar

Department of Pediatrics, Professor

- Shifali, Sri Guru Ram Das Institute of Medical Sciences and Research, Sri Amritsar, Amritsar

Department of Pediatrics, Professor

Downloads

Published

2016-06-02

How to Cite

Arora, S., & Shifali, .-. (2016). Cord Serum Bilirubin Level in Predicting the Development of Significant Hyperbilirubinemia in Newborns with ABO Incompatibility. Journal of Nepal Paediatric Society, 35(3), 231–236. https://doi.org/10.3126/jnps.v35i3.13797

Issue

Vol. 35 No. 3 (2015)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).